Hydroxychloroquine in Lupus: Strategies to Minimize Ocular Toxicity
The challenge: how to maintain therapeutic drug levels in the face of ocular toxicity.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
SUBSCRIBE: eNewsletter
Hydroxychloroquine in Lupus: Strategies to Minimize Ocular ToxicityApr 25, 2018 The challenge: how to maintain therapeutic drug levels in the face of ocular toxicity. |
In Youth Sports, Does It Pay to Specialize?Apr 25, 2018 The payout may be an increased risk of injury and burnout. |
Quiz: What Do You Know About Fibromyalgia?Apr 24, 2018 Recent studies have shed light on the pathophysiology, clinical diagnosis, and effective management of fibromyalgia. Are you up-to-date? |
The Hidden Toll of Lupus in Young WomenApr 23, 2018 Researchers analyzed mortality statistics from the CDC to determine the relative burden of SLE-related deaths among women. |
Atherosclerosis and CV Risk in LupusApr 23, 2018 Ground-breaking trials presented at the 2018 European Lupus Society meeting demonstrate that inexpensive office-based tools can predict impending cardiovascular disease in patients with lupus. |
Sjögren Syndrome: 5 True/False QuestionsApr 19, 2018 Find out how much you know about one of the most difficult chronic autoimmune disorders to manage. |
ACR Tackles the Rheumatology Workforce Shortage With a Novel CurriculumApr 19, 2018 The American College of Rheumatology developed a formal curriculum for NPs and PAs to help swell the ranks of clinicians who provide rheumatologic care. |
Deep Dive Into the Causes of DactylitisApr 18, 2018 Researchers look deep to find the cause of synovitis and dactylitis in patients with psoriatic arthritis. |
The Impact of Psoriatic Arthritis on Cardiovascular Risk FactorsApr 18, 2018 Which came first: the psoriatic arthritis or the cardiovascular risk factors? |
Predictors of Methotrexate Failure in Inflammatory PolyarthritisApr 17, 2018 RF positive, young with high disease activity . . . a big negative for MTX success. |